Literature DB >> 28819040

Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities.

Tina M Kaufman1, P Barton Duell1, Jonathan Q Purnell1, Cezary Wójcik1, Sergio Fazio1, Michael D Shapiro2.   

Abstract

Entities:  

Keywords:  angina, unstable; cholesterol, LDL; insurance, health; patient care; secondary prevention

Mesh：

Substances：

Year:  2017        PMID： 28819040     DOI： 10.1161/CIRCRESAHA.117.311532

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINE.

Authors:  Sergio Fazio; Michael D Shapiro
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

Review 2.  PCSK9: From Basic Science Discoveries to Clinical Trials.

Authors:  Michael D Shapiro; Hagai Tavori; Sergio Fazio
Journal:  Circ Res       Date:  2018-05-11       Impact factor: 17.367

3.  Application of PCSK9 Inhibitors in Practice.

Authors:  Tina M Kaufman; Bruce A Warden; Jessica Minnier; Joshua R Miles; P Barton Duell; Jonathan Q Purnell; Cezary Wojcik; Sergio Fazio; Michael D Shapiro
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

4.  Medication-based versus target-based lipid management.

Authors:  Sergio Fazio; Michael D Shapiro
Journal:  J Diabetes       Date:  2018-07-02       Impact factor: 4.006

5.  Low-density lipoprotein cholesterol lowering in real-world patients treated with evolocumab.

Authors:  Nihar R Desai; Rolin L Wade; Pin Xiang; Lionel Pinto; Sasikiran Nunna; Xin Wang; Jason Exter; Katherine E Mues; Mohdhar Habib; Chi-Chang Chen
Journal:  Clin Cardiol       Date:  2021-03-24       Impact factor: 2.882

6.  Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies.

Authors:  Carlota Oleaga; Michael D Shapiro; Joshua Hay; Paul A Mueller; Joshua Miles; Cecilia Huang; Emily Friz; Hagai Tavori; Peter P Toth; Cezary Wójcik; Bruce A Warden; Jonathan Q Purnell; P Barton Duell; Nathalie Pamir; Sergio Fazio
Journal:  J Am Coll Cardiol       Date:  2021-10-05       Impact factor: 24.094

7.  Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement.

Authors:  Bruce A Warden; Johannes Steiner; Albert Camacho; Khoa Nguyen; Jonathan Q Purnell; P Barton Duell; Courtney Craigan; Diane Osborn; Sergio Fazio
Journal:  Am J Prev Cardiol       Date:  2021-04-15

8.  Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol.

Authors:  Bruce A Warden; Joshua R Miles; Carlota Oleaga; Om P Ganda; P Barton Duell; Jonathan Q Purnell; Michael D Shapiro; Sergio Fazio
Journal:  Am J Prev Cardiol       Date:  2020-05-01

9.  Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practice.

Authors:  Bruce A Warden; Jonathan Q Purnell; P Barton Duell; Courtney Craigan; Diane Osborn; Emily Cabot; Sergio Fazio
Journal:  Am J Prev Cardiol       Date:  2021-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.